🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to compare the pharmacokinetics of naloxone when administer...
Status
Unknown
Location
International Pharmaceutical Research Center (IPRC)
Start Date
2012-06
Trial ID
NCT01622504
Treatments Being Tested
This will be a usability trial to assess administration of naloxone via int...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT03309449
Treatments Being Tested
This was a single-dose, randomized, double-blind, placebo-controlled, 3 way...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01595867
Treatments Being Tested
Intranasal (IN) naloxone is available as 2 mg or 4 mg dose with the indicat...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2021-03-01
Trial ID
NCT04764630
Opioid use disorders (OUD) are the second most common type of drug use diso...
Status
Unknown
Location
National Development and Research Institutes, Inc.
Start Date
2017-09-15
Trial ID
NCT03610672
Treatments Being Tested
Opioid overdoses have in the last decade counted for about 230 untimely dea...
Status
Completed
Location
Department of Circulation and Medical Imaging
Start Date
2016-03
Trial ID
NCT02598856
This study will be to determine the pharmacokinetics of naltrexone and nalo...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-05
Trial ID
NCT03851731
Treatments Being Tested
This project examines, in chronic pain, the mechanisms of immersive virtual...
Status
Active Not Recruiting
Location
Luana Colloca
Start Date
2021-11-01
Trial ID
NCT04851301
Treatments Being Tested
The goal of the proposed, proof-of-concept study is to test the combined ef...
Status
Terminated
Location
New York State Psychiatric Institute
Start Date
2021-11-01
Trial ID
NCT05114460
This study will be a Phase 1, single-center, open-label, randomized cross-o...
Status
Completed
Location
Syneos Health Clinical Research Services
Start Date
2022-03-28
Trial ID
NCT05377255
Treatments Being Tested